Factors associated with initial treatment response with antidepressants in bipolar disorder

European Neuropsychopharmacology

Volumn 21, Issue 5, 2011, Pages 362-369

  Pacchiarotti, I ^a   Valenti M ^a   Bonnin, C M ^a   Rosa, A R ^a   Murru, A ^a   Kotzalidis, G D ^a   Nivoli, A M A ^a   Sanchez Moreno J ^a   Vieta, E ^a   Colom, F ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Antidepressant drugs; Bipolar depression; Bipolar disorder; Clinical markers; Treatment outcome

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; MOOD STABILIZER;

ARTICLE; BIPOLAR DISORDER; DISEASE MARKER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SYMPTOMATOLOGY; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; TIME FACTORS; TREATMENT OUTCOME;

EID: 79953731140     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2010.10.002     Document Type: Article

References (44)

1. Altshuler L.L., Post R.M., Hellemann G., Leverich G.S., Nolen W.A., Frye M.A., Keck P.E., Kupka R.W., Gruñes H., McElroy S.L., Sugar C.A., Suples T. Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study. J. Clin. Psychiatry 2009, 70:450-457.
2. Amsterdam J.D., Shults J. Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study. Am. J. Psychiatry 2010, Apr 1. [Epub ahead of print]PMID: 20360317.
3. Baldessarini R.J., Leahy L., Arcona S., Gause D., Zhang W., Hennen J. Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders. Psychiatr. Serv. 2007, 58:85-91.
4. Bobes J., Bulbena A., Luque A., Dal Re R., Ballesteros J., Ibarra N. A comparative psychometric study of the Spanish versions with 6, 17, and 21 items of the Hamilton Depression Rating Scale. Med. Clin. Barc. 2003, 120:693-700.
5. Bottlender R., Rudolf D., Jäger M., Strauss A., Möller H.J. Are bipolar I depressive patients less responsive to treatment with antidepressants than unipolar depressive patients? Results from a case control study. Eur. Psychiatry 2002, 17:200-205.
6. Colom F., Vieta E., Martinez-Aran A., Garcia-Garcia M., Reinares M., Torrent C., Goikolea J.M., Banús S., Salamero M. Spanish version of a scale for the assessment of mania: validity and reliability of the Young Mania Rating Scale. Med. Clin. Barc. 2002, 119:366-371.
7. Colom F., Vieta E., Daban C., Pacchiarotti I., Sánchez-Moreno J. Clinical and therapeutic implications of predominant polarity in bipolar disorder. J. Affect. Disord. 2006, 93:13-17.
8. Davis L.L., Wisniewski S.R., Howland R.H., Trivedi M.H., Husain M.M., Fava M., McGrath P.J., Balasubramani G.K., Warden D., Rush A.J. Does comorbid substance use disorder impair recovery from major depression with SSRI treatment? An analysis of the STAR*D level one treatment outcomes. Drug Alcohol Depend. 2010, 107:161-170.
9. First M.B., Spitzer R., Gibbon M. Structured clinical interview for DSM-IV Axis I disorders 1997, American Psychiatric Press Inc, Washington DC.
10. First M.B., Spitzer R., Gibbon M. Structured clinical interview for DSM-IV axis II personality disorders 1997, American Psychiatric Press Inc, Washington DC.
11. Ghaemi S.N., Rosenquist K.J., Ko J.Y., Baldassano C.F., Kontos N.J., Baldessarini R.J. Antidepressant treatment in bipolar versus unipolar depression. Am. J. Psychiatry 2004, 161:163-165.
12. Ghaemi S.N., Hsu D.J., Thase M.E., Wisniewski S.R., Nierenberg A.A., Miyahara S., Sachs G. Pharmacological treatment patterns at study entry for the first 500 step-bd participants. Psychiatr. Serv. 2006, 57:660-665.
13. Ghaemi S.N., Wingo A.P., Filkowski M.A., Baldessarini R.J. Long-term antidepressant treatment in bipolar disorder: meta-analyses of benefits and risks. Acta Psychiatr. Scand. 2008, 118:347-356.
14. Ghaemi S.N., Ostacher M.M., El-Mallakh R.S., Borrelli D., Baldassano C.F., Kelley M.E., Filkowski M.M., Hennen J., Sachs G.S., Goodwin F.K., Baldessarini R.J. Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety. J. Clin. Psychiatry 2010, 71:372-380.
15. Gijsman H.J., Geddes J.R., Rendell J.M., Nolen W.A., Goodwin G.M. Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. Am. J. Psychiatry 2004, 161:1537-1547.
16. Goldberg J.F., Truman C.J. Antidepressant-induced mania: an overview of current controversies. Bipolar Disord. 2003, 5:407-420.
17. Goldberg J.F., Perlis R.H., Ghaemi S.N., Calabrese J.R., Bowden C.L., Wisniewski S., Miklowitz D.J., Sachs G.S., Thase M.E. Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD. Am. J. Psychiatry 2007, 164:1348-1355.
18. Grunze H.C. Switching, induction of rapid cycling, and increased suicidality with antidepressants in bipolar patients: fact or overinterpretation?. C.N.S. Spectrochim 2008, 13:790-795.
19. Hamilton M. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 1967, 6:278-296.
20. Henkel V., Seemüller F., Obermeier M., Adli M., Bauer M., Mundt C., Brieger P., Laux G., Bender W., Heuser I., Zeiler J., Gaebel W., Mayr A., Möller H.J., Riedel M. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression. J. Affect. Disord. 2009, 115:439-449.
21. Hennings J.M., Owashi T., Binder E.B., Horstmann S., Menke A., Kloiber S., Dose T., Wollweber B., Spieler D., Messer T., Lutz R., Künzel H., Bierner T., Pollmächer T., Pfister H., Nickel T., Sonntag A., Uhr M., Ising M., Holsboer F., Lucae S. Clinical characteristics and treatment outcome in a representative sample of depressed inpatients -findings from the Munich Antidepressant Response Signature (MARS) project. J. Psychiatr. Res. 2008, 43:215-229.
22. Howland R.H., Rush A.J., Wisniewski S.R., Trivedi M.H., Warden D., Fava M., Davis L.L., Balasubramani G.K., McGrath P.J., Berman S.R. Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome. Drug Alcohol Depend. 2009, 99:248-260.
23. Kemp D.E., Gao K., Ganocy S.J., Caldes E., Feldman K., Chan P.K., Conroy C., Bilali S., Findling R.L., Calabrese J.R. Medical and substance use comorbidity in bipolar disorder. J. Affect. Disord. 2009, 116:64-69.
24. Khan A., Leventhal R.M., Khan S.R., Brown W.A. Severity of depression and response to antidepressants and placebo: an analysis of the Food and Drug Administration database. J. Clin. Psychopharmacol. 2002, 22:40-45.
25. Khan A., Brodhead A.E., Kolts R.L., Brown W.A. Severity of depressive symptoms and response to antidepressants and placebo in antidepressant trials. J. Psychiatr. Res. 2005, 39:145-150.
26. Licht R.W., Gijsman H., Nolen W.A., Angst J. Are antidepressants safe in the treatment of bipolar depression? A critical evaluation of their potential risk to induce switch into mania or cycle acceleration. Acta Psychiatr. Scand. 2008, 118:337-346.
27. Mazzarini L., Pacchiarotti I., Colom F., Sani G., Kotzalidis G.D., Rosa A.R., Sanna L., De Rossi P., Girardi N., Bonnin C.M., Sanchez-Moreno J., Vazquez G.H., Gasto C., Tatarelli R., Vieta E. Predominant polarity and temperament in bipolar and unipolar affective disorders. J. Affect. Disord. 2009, 119:28-33.
28. Mazzarini L., Colom F., Pacchiarotti I., Nivoli A.M., Murru A., Bonnin C.M., Cruz N., Sanchez-Moreno J., Kotzalidis G.D., Girardi P., Tatarelli R., Vieta E. Psychotic versus non-psychotic bipolar II disorder. J. Affect. Disord. 2010, [Epub ahead of print]PMID: 20457470 [PubMed-as supplied by publisher].
29. Pacchiarotti I., Mazzarini L., Colom F., Sanchez-Moreno J., Girardi P., Kotzalidis G.D., Vieta E. Treatment-resistant bipolar depression: towards a new definition. Acta Psychiatr. Scand. 2009, 120:429-440.
30. Post R.M., Leverich G.S., Nolen W.A., Kupka R.W., Altshuler L.L., Frye M.A., Suppes T., McElroy S., Keck P., Grunze H., Walden J. A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network. Bipolar Disord. 2003, 5:396-406.
31. Post R.M., Altshuler L.L., Leverich G.S., Frye M.A., Nolen W.A., Kupka R.W., Suppes T., McElroy S., Keck P.E., Denicoff K.D., Grunze H., Walden J., Kitchen C.M., Mintz J. Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. Br. J. Psychiatry 2006, 189:124-131.
32. Rosa A.R., Andreazza A.C., Kunz M., Gomes F., Santin A., Sanchez-Moreno J., Reinares M., Colom F., Vieta E., Kapczinski F. Predominant polarity in bipolar disorder: diagnostic implications. J. Affect. Disord. 2008, 107:45-51.
33. Rosa A.R., Cruz N., Franco C., Haro J.M., Bertsch J., Reed C., Aarre T.F., Sanchez-Moreno J., Vieta E. Why do clinicians maintain antidepressants in some patients with acute mania? Hints from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM), a large naturalistic study. J. Clin. Psychiatry 2010, [Epub ahead of print]PMID: 20361912 [PubMed-as supplied by publisher].
34. Rush A.J., Trivedi M.H., Wisniewski S.R., Nierenberg A.A., Stewart J.W., Warden D., Niederehe G., Thase M.E., Lavori P.W., Lebowitz B.D., McGrath P.J., Rosenbaum J.F., Sackeim H.A., Kupfer D.J., Luther J., Fava M. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am. J. Psychiatry 2006, 163:905-917.
35. Sachs G.S., Nierenberg A.A., Calabrese J.R., Marangell L.B., Wisniewski S.R., Gyulai L., Friedman E.S., Bowden C.L., Fossey M.D., Ostacher M.J., Ketter T.A., Patel J., Hauser P., Rapport D., Martinez J.M., Allen M.H., Miklowitz D.J., Otto M.W., Dennehy E.B., Thase M.E. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J. Med. 2007, 356:1711-1722.
36. Seemüller F., Riedel M., Obermeier M., Bauer M., Adli M., Kronmüller K., Holsboer F., Brieger P., Laux G., Bender W., Heuser I., Zeiler J., Gaebel W., Dichgans E., Bottländer R., Musil R., Möller H.J. Outcomes of 1014 naturalistically treated inpatients with major depressive episode. Eur. Neuropsychopharmacol. 2010, 20:346-355.
37. Sharma V., Khan M., Smith A. A closer look at treatment resistant depression: is it due to a bipolar diathesis?. J. Affect. Disord. 2005, 84:251-257.
38. Smith D.J., Forty L., Russell E., Caesar S., Walters J., Cooper C., Jones I., Jones L., Craddock N. Sub-threshold manic symptoms in recurrent major depressive disorder are a marker for poor outcome. Acta Psychiatr. Scand. 2009, 119:325-329.
39. Stewart J.W., McGrath P.J., Fava M., Wisniewski S.R., Zisook S., Cook I., Nierenberg A.A., Trivedi M.H., Balasubramani G.K., Warden D., Lesser I., John Rush A. Do atypical features affect outcome in depressed outpatients treated with citalopram?. Int. J. Neuropsychopharmacol. 2010, 13:15-30.
40. Tohen M., Frank E., Bowden C.L., Colom F., Ghaemi S.N., Yatham L.N., Malhi G.S., Calabrese J.R., Nolen W.A., Vieta E., Kapczinski F., Goodwin G.M., Suppes T., Sachs G.S., Chengappa K.R., Grunze H., Mitchell P.B., Kanba S., Berk M. The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord. 2009, 11:453-473.
41. Vieta E. Antidepressants in bipolar depression. Acta Psychiatr. Scand. 2008, 118:335-336.
42. Vieta E., Martinez-Arán A., Goikolea J.M., Torrent C., Colom F., Benabarre A., Reinares M. A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers. J. Clin. Psychiatry 2002, 63:508-512.
43. Vieta E., Berk M., Wang W., Colom F., Tohen M., Baldessarini R.J. Predominant previous polarity as an outcome predictor in a controlled treatment trial for depression in bipolar I disorder patients. J. Affect. Disord. 2009, 119:22-27.
44. Young R.C., Biggs J.T., Ziegler V.E., Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. Br. J. Psychiatry 1978, 133:429-435.